1. Home
  2. VSAT vs VERA Comparison

VSAT vs VERA Comparison

Compare VSAT & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ViaSat Inc.

VSAT

ViaSat Inc.

HOLD

Current Price

$81.32

Market Cap

9.7B

Sector

Technology

ML Signal

HOLD

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$35.52

Market Cap

3.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VSAT
VERA
Founded
1986
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
3.2B
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
VSAT
VERA
Price
$81.32
$35.52
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
10
Target Price
$59.80
$81.30
AVG Volume (30 Days)
1.8M
909.4K
Earning Date
05-19-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
50.88
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$5.32
N/A
Revenue Next Year
$3.57
$472.48
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.28
$19.07
52 Week High
$89.79
$56.05

Technical Indicators

Market Signals
Indicator
VSAT
VERA
Relative Strength Index (RSI) 65.28 46.16
Support Level $29.68 $33.43
Resistance Level N/A $42.77
Average True Range (ATR) 5.04 1.94
MACD 0.96 0.11
Stochastic Oscillator 67.50 38.42

Price Performance

Historical Comparison
VSAT
VERA

About VSAT ViaSat Inc.

Viasat Inc provides bandwidth technologies and services in three segments: communication services and defense and advanced technologies. The communication services segment provides a wide range of broadband and narrowband communications solutions across government and commercial mobility markets, as well as for residential and enterprise fixed broadband customers: and the defense and advanced technologies segment develops and offers a diverse array of resilient, vertically integrated solutions to government and commercial customers, leveraging core technical competencies in encryption, cyber security, tactical gateways, modems and waveforms. A large majority of the firm's revenue is generated from communication services segment.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: